Roivant Sciences ROIV
NASDAQ ROIV
$36.22 -0.35 (-0.97%)
As of: Oct 1, 2026 · 2:24 PM EDT

Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2026)

Updated

Roivant Sciences' Other Non-Current Assets came in at $29.59 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 4.9% from $31.09 million a year earlier and down 27.7% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences' Other Non-Current Assets was $40.92 million, up 24.5% from FY2025.

  • Other Non-Current Assets carries a five-year compound annual growth rate of -13.9% (FY2021 to FY2026).
  • Going back by fiscal year, Other Non-Current Assets was $32.86 million in FY2025 (-77.5%), $145.88 million in FY2024 (+194.8%), $49.48 million in FY2023 (+91.6%) and $25.82 million in FY2022 (-70.2%).
  • The five-year range for quarterly Other Non-Current Assets is $11.87 million (fiscal Q2 2023) to $145.88 million (fiscal Q4 2024).
  • Year-over-year, Other Non-Current Assets increased in two of the last eight quarters, with an average decline of 17.4%.
  • The fastest year-over-year change in Other Non-Current Assets over five years came in fiscal Q2 2024 (growth of 319.4%), and the weakest in fiscal Q4 2025 (a decline of 77.5%).
  • Business Quant data shows ROIV's Other Non-Current Assets at $40.92 million (Q4 2026), $34.56 million (Q3 2026) and $27.83 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Roivant Sciences 26.43 Bn 27.12 Bn 1.16 Mn 29.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 29.59 Mn
Mar 31, 2026 40.92 Mn
Dec 31, 2025 34.56 Mn
Sep 30, 2025 27.83 Mn
Jun 30, 2025 31.09 Mn
Mar 31, 2025 32.86 Mn
Dec 31, 2024 33.88 Mn
Sep 30, 2024 36.90 Mn
Jun 30, 2024 32.81 Mn
Mar 31, 2024 145.88 Mn
Dec 31, 2023 46.85 Mn
Sep 30, 2023 49.80 Mn
Jun 30, 2023 46.31 Mn
Mar 31, 2023 49.48 Mn
Dec 31, 2022 46.22 Mn
Sep 30, 2022 11.87 Mn
Jun 30, 2022 14.25 Mn
Mar 31, 2022 25.82 Mn
Dec 31, 2021 20.88 Mn
Sep 30, 2021 21.34 Mn
API Access

Roivant Sciences Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ROIV&period=max&api_key=YOUR_API_KEY